Balyasny Asset Management’s CASTLIGHT HEALTH, INC. CSLT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-40,538
Closed -$107K 2616
2021
Q2
$107K Buy
40,538
+24,878
+159% +$46.3K ﹤0.01% 1792
2021
Q1
$24K Buy
+15,660
New +$27.2K ﹤0.01% 1704
2018
Q3
Sell
-18,691
Closed -$79K 2171
2018
Q2
$79K Sell
18,691
-9,909
-35% -$37.2K ﹤0.01% 1719
2018
Q1
$104K Buy
28,600
+15,200
+113% +$56.4K ﹤0.01% 1827
2017
Q4
$50K Buy
+13,400
New +$53.6K ﹤0.01% 2013

Other funds holding CSLT

Balyasny Asset Management's CSLT Position: Q3 2021 in Review

Balyasny Asset Management sold out of CASTLIGHT HEALTH, INC. (CSLT) in Q3 2021, closing a stake of 40,538 shares — an estimated $107K sold.

Balyasny Asset Management first reported a position in CSLT in Q4 2017 and held it in 5 quarters. The position peaked at $107K in Q2 2021. 106 funds tracked by Wall St. Rank hold CSLT as of Q3 2021.

  • Balyasny Asset Management reported no remaining CASTLIGHT HEALTH, INC. position as of Q3 2021 after selling out during the quarter.
  • Balyasny Asset Management sold 40,538 CASTLIGHT HEALTH, INC. shares in Q3 2021, an estimated $107K.
  • Balyasny Asset Management first reported a position in CASTLIGHT HEALTH, INC. in Q4 2017 and held it in 5 quarters.
  • Balyasny Asset Management's CASTLIGHT HEALTH, INC. position peaked at $107K in Q2 2021.
  • 106 funds tracked by Wall St. Rank held CASTLIGHT HEALTH, INC. as of Q3 2021.

Based on Balyasny Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.